Efficacy and cost-benefit of filgrastim administered after early assessment bone marrow biopsy during induction therapy for acute myeloid leukemia

Jiasheng Wanga Seidman Cancer Center, University Hospitals Cleveland Medical Center, Cleveland, OH, USA

Marcos de Limaa Seidman Cancer Center, University Hospitals Cleveland Medical Center, Cleveland, OH, USA

Brenda W. Coopera Seidman Cancer Center, University Hospitals Cleveland Medical Center, Cleveland, OH, USA

Kirsten Boughana Seidman Cancer Center, University Hospitals Cleveland Medical Center, Cleveland, OH, USA

Leland Methenya Seidman Cancer Center, University Hospitals Cleveland Medical Center, Cleveland, OH, USA

Folashade Otegbeyea Seidman Cancer Center, University Hospitals Cleveland Medical Center, Cleveland, OH, USA

Paolo F. Caimia Seidman Cancer Center, University Hospitals Cleveland Medical Center, Cleveland, OH, USA

Molly Galloglya Seidman Cancer Center, University Hospitals Cleveland Medical Center, Cleveland, OH, USA

Ehsan Maleka Seidman Cancer Center, University Hospitals Cleveland Medical Center, Cleveland, OH, USA

Shufen Caoa Seidman Cancer Center, University Hospitals Cleveland Medical Center, Cleveland, OH, USA

Pingfu Fua Seidman Cancer Center, University Hospitals Cleveland Medical Center, Cleveland, OH, USA

Brett Glotzbeckera Seidman Cancer Center, University Hospitals Cleveland Medical Center, Cleveland, OH, USA

Nicholas K. Schiltzb Francis Payne School of Nursing, Case Western Reserve University, Case Western Reserve University, Cleveland, OH, USA

Benjamin K. Tomlinsona Seidman Cancer Center, University Hospitals Cleveland Medical Center, Cleveland, OH, USACorrespondence[email protected]

Your download is now in progress and you may close this window